Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

how to invest in biotech

Article Index

Biotech ETFs Are Now Discounted for 2016 After Sell-Off

Dow Jone

Biotech stocks have gotten crushed in recent weeks, with the Nasdaq Biotechnology Index falling 15.5% in the last month and 25% from its July highs.

And while many investors are taking their money to the sideline, this is actually a great time to invest in biotech ETFs with 2016 in mind.

Here's the biotech ETF we're recommending now...

Biotech Investing Buff Just Made $1.1 Billion Profit in 8 Months – Here's How

Biotech Investing

With a net worth of $12.6 billion, Patrick Soon-Shiong, MD, is the world's richest doctor, the richest American in the healthcare industry, and the 96th-richest person on the planet in 2015 according to Forbes.

And just in August, the 63-year-old became $1.1 billion richer -- from a move he'd made only eight months prior, according to Bloomberg...

Here's Soon-Shiong's story - plus five ways you can cash in with biotech profits of your own...

"21st Century Cures" Could Revolutionize Biotech

No one is thrilled with the way new drugs and medical devices come to market in the U.S. - not the biotech and pharmaceutical companies, not the regulators at the Food and Drug Administration (FDA) or National Institutes of Health (NIH), not physicians, and certainly not patients desperately in need of new therapies.

The process is hugely expensive and incredibly slow. According to the Tuft's Center for the Study of Drug Development, the average cost of bringing a new prescription drug from lab to market now tops $2.5 billion and takes more than 10 years.

That can make for a real thrill ride where investors are concerned, as share price for a pre-profit biotech can rise and fall dramatically and unpredictably with every related data release, financial report, news item, or regulatory hiccup over an entire decade, making long-term investment a crapshoot, at best.

But new regulations on the table could change everything for biotech investors and critically ill patients...

How to Find the Best Biotech Shares – Every Time

When you're evaluating most new stocks, it makes good sense to look at technical indicators - such as price-to-earnings ratio (P/E), profit margins, or revenue per share, to name a couple - so you know what you're buying.

But here's the rub. When you're scouting a promising biotech stock, those indicators I mentioned just won't tell you what you need to know.

Of course we're dealing with a sector that can hand out uncommonly large profits, so our approach needs to be a little different.

Weigh these before you take your next biotech position, and you'll enjoy much bigger potential profits and lower your risk...

60 Biotech Companies to Go Public Before April 1

biotech companies

Biotechnology is tech's fastest-growing sector. In fact, there are more than 100 biotech companies set to go public in 2015.

Of those 100 IPOs, 60 are expected to launch before April 1. So you have to move fast to ride this $320 billion biotech wave.

Those IPOs are all but certain to keep the biotech bull market going through the year. Biotech stocks have soared 290% in the past five years. That's more than triple the S&P's 88%.

And biotech IPOs are not the only catalysts that will lift biotech shares across the board in 2015.

One Stock That Will Profit from a New, Breakthrough Medical Direction

Modern medicine, for all of its sophisticated drugs, complex gadgets, and amazing surgical procedures, rarely cures anything. It treats. It manages. It postpones the inevitable.

But return a patient to normal, optimal health?

Seldom...

So when an innovation comes along that can effect a complete and permanent remission of disease or restore damaged organs to a pristine state, it should cause your keenest investing instincts to perk up and pay attention...

Two Biotech Stocks Set to Double on One Powerful Catalyst

biotech stocks

[Editor’s Note: We’re sharing this edition of Private Briefing with you because the two profit-doublers Bill is looking at right now are about to break out, thanks to a little-understood catalyst that heralds big share price hikes. Here’s Bill…]

When I earned my MBA from the Rochester Institute of Technology back in the mid-1990s, my focus was finance and investing.

But it was a management professor who clued me in to some of the best ways to "look past the numbers" and understand what really makes a big company tick.

The professor, Janet C. Barnard, retired a few years back and, sadly, passed away in 2012.

The talks that she and I had were invigorating "mini-lessons" - which is why we were still having them years after I tacked my graduate-degree diploma to my office wall.

I often "shared" those lessons with my readers - quoting the management professor in stories I wrote back during my days at The Baltimore Sun, as well as in columns I've written for you folks here at Money Map Press.

Now those lessons will pay off again as we look at these huge biotech opportunities...

The Best Biotech Stocks for 2013 Are Now Within Your Reach

Biotech stocks are soaring in 2013 as major innovations in healthcare have offered enormous breakthroughs on once-untreatable diseases and conditions.

But for years, it was tricky to invest in some of today's best biotech companies given their volatility and uncertainty in the industry. For the better part of five years, some of today's leading biotech stocks remained essentially flat.

For some time, it was best to stick to large-scale pharmaceutical companies with a strong yield and avoid mass speculation in hit-or-miss penny stocks.

Well, not any more. Shares of the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) - which tracks industry returns - are up a staggering 42% since the beginning of the year, and the health/biotech industry has the highest returns of any sector for the year.

And you haven't seen anything yet...

With one of the most exciting biotech companies now joining the NYSE and another setting its focus on an uplisting, we're seeing major changes in the biotech industry and investment. And there are companies poised to become the best biotech stocks you can find right now.

To continue reading, please click here...

How to Invest in Biotech Now and Double Your Money

Some of the most lucrative opportunities you can find now are in the biotechnology industry – which is why we've been working to uncover the best ways for how to invest in this sector.

The best biotech companies overflow with innovation. They can offer a steady stream of game-changing products – which often translates to record-breaking revenue.

The biotech industry is also known for its stiff competition. The race to be a consumer favorite causes companies to take big risks.

Sometimes, these lead to embarrassing flops, but when they get it right, the payoffs are huge.

That's a big reason why funding, often difficult to secure, is getting easier. Read more...